177 related articles for article (PubMed ID: 20460540)
1. Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.
Song EY; Shurin MR; Tourkova IL; Gutkin DW; Shurin GV
Cancer Res; 2010 Jun; 70(11):4394-401. PubMed ID: 20460540
[TBL] [Abstract][Full Text] [Related]
2. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Cao B; Yang Y; Pan Y; Jia Y; Brock MV; Herman JG; Guo M
Discov Med; 2013 Oct; 16(88):137-47. PubMed ID: 24099668
[TBL] [Abstract][Full Text] [Related]
5. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
6. ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer.
Liu JW; Nagpal JK; Sun W; Lee J; Kim MS; Ostrow KL; Zhou S; Jeronimo C; Henrique R; Van Criekinge W; Moon CS; Califano JA; Trink B; Sidransky D
Clin Cancer Res; 2008 Jun; 14(12):3754-60. PubMed ID: 18559593
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling.
Guo J; Chang C; Yang LY; Cai HQ; Chen DX; Zhang Y; Cai Y; Wang JJ; Wei WQ; Hao JJ; Wang MR
Biochem Biophys Res Commun; 2022 Jun; 609():75-83. PubMed ID: 35421632
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
11. The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling.
Wang C; Zhao N; Sato F; Tanimoto K; Okada H; Liu Y; Bhawal UK
Bioengineered; 2021 Dec; 12(2):9128-9139. PubMed ID: 34696665
[TBL] [Abstract][Full Text] [Related]
12. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
Mavis CK; Morey Kinney SR; Foster BA; Karpf AR
Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856
[TBL] [Abstract][Full Text] [Related]
13. The Epigenetic Modifier 5-Aza-2-deoxycytidine Triggers the Expression of
Dudzik P; Trojan SE; Ostrowska B; Zemanek G; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Anticancer Res; 2019 May; 39(5):2395-2403. PubMed ID: 31092432
[TBL] [Abstract][Full Text] [Related]
14. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
15. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
20. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
